PLCε regulates podocyte differentiation and TGF-β1 responses via alteration of SMAD2/SMAD3 ratio

Area of Science:

• Nephrology
• Molecular Biology
• Genetics

Background:

• Genetic mutations in PLCε1 are linked to early-onset nephrotic syndrome (NS) and diffuse mesangial sclerosis (DMS).
• The precise mechanisms by which PLCε1 mutations affect podocyte biology, particularly differentiation, remain largely unknown.

Purpose of the Study:

• To investigate the role of Phospholipase C epsilon (PLCε) in human podocyte biology.
• To elucidate the functional consequences of PLCε deficiency in podocytes, especially in the context of nephrotic syndrome.

Main Methods:

• Generation of a conditionally immortalized human podocyte cell line from a patient with a nonsense PLCε1 mutation causing NS and DMS.
• Comparison of PLCε1 mutant podocytes with wild-type podocytes, assessing epithelial features, actin cytoskeleton, ZO-1 expression, and response to TGF-β1.

Main Results:

• PLCε1 mutant podocytes exhibited reduced epithelial characteristics, altered actin cytoskeleton, and decreased levels of the epithelial marker ZO-1 compared to wild-type cells.
• PLCε deficiency led to impaired TGF-β1 responses, characterized by an altered SMAD2/SMAD3 ratio, absent SMAD2 phosphorylation, and a loss of motility in response to TGF-β1.
• Knockdown of PLCε1 in wild-type podocytes replicated the observed phenotype, confirming the role of PLCε deficiency.

Conclusions:

• PLCε deficiency is associated with podocyte dedifferentiation, characterized by loss of epithelial features and impaired response to TGF-β1 signaling.
• This study reveals a novel link between PLCε1 deficiency and the SMAD2/3 signaling pathway in maintaining podocyte differentiation.
• Disease-causing mutations in PLCε1 contribute to nephrotic syndrome through mechanisms involving podocyte dedifferentiation and disrupted SMAD signaling.